Novel Signalings and Molecular Targets of Endothelial Regeneration in Aging Lung
衰老肺内皮再生的新信号传导和分子靶点
基本信息
- 批准号:8909182
- 负责人:
- 金额:$ 39.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-15 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAddressAdult Respiratory Distress SyndromeAgingAnimal ModelAnimalsBlood VesselsCXCR4 ReceptorsCXCR4 geneCellsComplexDataEdemaElderlyEndotheliumExtravasationFluid BalanceG Protein-Coupled Receptor GenesGoalsHealthHomeostasisHumanHypoxemiaHypoxia Inducible FactorIncidenceInfiltrationInflammatoryInjuryLigationLungLung InflammationMediator of activation proteinMolecularMolecular TargetMusNatural regenerationOutcomeOxygenPathway interactionsPatientsProcollagen-Proline DioxygenaseProtein IsoformsProteinsPulmonary EdemaPuncture procedureRecoveryResolutionRoleSecondary toSepsisSeveritiesSignal TransductionStromal Cell-Derived Factor 1SyndromeTherapeuticTranscriptional RegulationUrsidae FamilyVascular Endothelial CellVascular Permeabilitiesagedclinically relevantforkhead proteinimprovedlung injurylung vascular injurymortalitynovelnovel therapeutic interventionnovel therapeuticsolder patientprogramsrepairedrestorationsensortherapeutic target
项目摘要
DESCRIPTION (provided by applicant): An essential component of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is that injury of the endothelial barrier of pulmonary microvessels results in persistent increase in lung vascular permeability to protein and intractable protein-rich edema formation. Compared to young patients, the incidence of ALI/ARDS resulting from sepsis in elderly patients is as much as 19-fold greater and the mortality rate is up to 10-fold greater. However, the underlying causes are poorly understood. Also crucially little is known how aging influences mechanisms of endothelial regeneration and restoration of vascular homeostasis following sepsis challenge. We have recently shown that the Forkhead transcription factor FoxM1 is a key reparative factor responsible for endothelial regeneration. However, our new Supporting Data presented here show that FoxM1 expression and the endogenous endothelial regeneration program were severely impaired in aged lungs following inflammatory lung injury. We observed that endothelial hypoxia-inducible factor HIF-1a is the critical mediator of FoxM1 expression through transcriptional control of SDF-1a which activates CXCR4 receptor leading to activation of the GPCR-dependent p110gamma isoform of PI3K, and that inhibition of the oxygen sensors HIF prolyl hydroxylase (PHDs) re-induced FoxM1 expression and activated the endothelial regeneration program in aged lungs. Thus, we hypothesize that impaired HIF- 1a->FoxM1 signaling secondary to activation of PHD2 in aged lungs is responsible for the severely defective endothelial regeneration in these lungs, and activation of this fundamental reparative pathway through PHD2 inhibition and CXCR4 activation is a potential novel therapeutic approach for reversing lung microvessel leakiness and improving survival of elderly ALI/ARDS patients. The proposed studies address the following Specific Aims. In Aim #1, we will address the role of impaired HIF-1a->FoxM1 signaling in aged lungs as a crucial factor responsible for severely impaired endothelial regeneration and restoration of lung vascular homeostasis following sepsis challenge. In Aim #2, we will delineate the signaling mechanisms underlying severely defective endothelial regeneration in aged lungs following sepsis challenge. In Aim #3, we will determine the role of HIF-1a stabilization through PHD inhibition in activating endothelial regeneration in aged lungs. We will also address the potential clinical relevance of our findings in animal models to humans; thereby determine the therapeutic implications of inhibition of PHD2 and activation of CXCR4 in treatment of ALI/ARDS of elderly patients. With these comprehensive studies, we will delineate the fundamental signaling mechanisms of impaired endothelial regeneration in aged lungs, and identify therapeutic targets to activate this fundamental intrinsic HIF-1a->FoxM1-dependent mechanisms to repair leaky lung microvessels for the treatment of ALI/ARDS in elderly patients.
描述(由申请人提供):急性肺损伤(ALI)和急性呼吸窘迫综合征(ARDS)的重要组成部分是,肺部微丝的内皮屏障的损伤导致肺血管通透性持续增加对蛋白质和可怕的蛋白质含量蛋白质富含蛋白质含量。与年轻患者相比,老年患者败血症引起的ALI/ARD的发生率高达19倍,死亡率高达10倍。但是,基本原因知之甚少。同样至关重要的是,衰老挑战挑战后,衰老如何影响内皮再生的机制和血管稳态的恢复。我们最近表明,叉状转录因子FOXM1是负责内皮再生的关键修复因子。但是,我们在此提供的新支持数据表明,在炎症肺损伤后,FOXM1表达和内源性内皮再生计划在老年肺部受到严重损害。 We observed that endothelial hypoxia-inducible factor HIF-1a is the critical mediator of FoxM1 expression through transcriptional control of SDF-1a which activates CXCR4 receptor leading to activation of the GPCR-dependent p110gamma isoform of PI3K, and that inhibition of the oxygen sensors HIF prolyl hydroxylase (PHDs) re-induced FoxM1 expression and activated the老年肺的内皮再生计划。因此,我们假设在老年肺中激活PHD2继发的HIF-1A-> FOXM1信号受损是这些肺中严重缺陷的内皮再生的原因,并且通过PHD2抑制作用和CXCR4激活的一种基本修复途径的激活是一种潜在的新型频率,用于泄漏的频率且频率的范围差异,差异是差异的,该方法的差异是差异的范围。 ALI/ARDS患者。拟议的研究针对以下特定目的。在AIM#1中,我们将解决HIF-1A-> FOXM1信号在老年肺中受损的作用,这是导致败血症挑战后肺血管稳态严重受损的至关重要因素。在AIM#2中,我们将描述败血症挑战后老化肺部严重缺陷内皮再生的信号传导机制。在AIM#3中,我们将通过抑制PHD抑制HIF-1A稳定在激活老年肺的内皮再生中的作用。我们还将解决动物模型中我们发现与人类的潜在临床相关性;从而确定抑制PHD2的治疗意义和CXCR4在治疗老年患者ALI/ARD中的激活。通过这些全面的研究,我们将描述老年肺内皮再生受损的基本信号传导机制,并鉴定治疗靶标,以激活这种基本的内在HIF-1A-> FOXM1依赖性机制,以修复漏水的肺微病房,以治疗ALI/ARD患者的ALI/ARD患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOU-YANG ZHAO其他文献
YOU-YANG ZHAO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOU-YANG ZHAO', 18)}}的其他基金
Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH
RNA修饰在肺血管重塑和PAH发病机制中的新作用
- 批准号:
10540134 - 财政年份:2022
- 资助金额:
$ 39.28万 - 项目类别:
Negative regulators of endothelial regeneration in aging lungs and ARDS
衰老肺和 ARDS 中内皮再生的负调节因子
- 批准号:
10467781 - 财政年份:2022
- 资助金额:
$ 39.28万 - 项目类别:
Negative regulators of endothelial regeneration in aging lungs and ARDS
衰老肺和 ARDS 中内皮再生的负调节因子
- 批准号:
10629328 - 财政年份:2022
- 资助金额:
$ 39.28万 - 项目类别:
Novel mechanisms of endothelial Injury in the pathogenesis of ARDS
ARDS发病机制中内皮损伤的新机制
- 批准号:
10434658 - 财政年份:2020
- 资助金额:
$ 39.28万 - 项目类别:
Novel mechanisms of endothelial Injury in the pathogenesis of ARDS
ARDS发病机制中内皮损伤的新机制
- 批准号:
10618326 - 财政年份:2020
- 资助金额:
$ 39.28万 - 项目类别:
Targeting Smooth Muscle Progenitor Cells for Treatment of Pulmonary Arterial Hypertension
靶向平滑肌祖细胞治疗肺动脉高压
- 批准号:
10189689 - 财政年份:2018
- 资助金额:
$ 39.28万 - 项目类别:
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension
闭塞性肺血管重塑和严重肺动脉高压的新机制
- 批准号:
10470871 - 财政年份:2016
- 资助金额:
$ 39.28万 - 项目类别:
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension
闭塞性肺血管重塑和严重肺动脉高压的新机制
- 批准号:
10316765 - 财政年份:2016
- 资助金额:
$ 39.28万 - 项目类别:
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension
闭塞性肺血管重塑和严重肺动脉高压的新机制
- 批准号:
10677597 - 财政年份:2016
- 资助金额:
$ 39.28万 - 项目类别:
Novel Signalings and Molecular Targets of Endothelial Regeneration in Aging Lung
衰老肺内皮再生的新信号传导和分子靶点
- 批准号:
9307973 - 财政年份:2014
- 资助金额:
$ 39.28万 - 项目类别:
相似国自然基金
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于巨噬细胞炎性小体活化探究木犀草素治疗急性肺损伤的新机制
- 批准号:82374186
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
CDK4/6抑制下调衰老中性粒细胞促炎效应改善急性肺损伤的机制和干预研究
- 批准号:82302445
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于肺间充质干细胞源外泌体lncRNA表达谱差异探讨益气活血解毒法改善脓毒症急性肺损伤的机制
- 批准号:82374400
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
Understanding Chirality at Cell-Cell Junctions With Microscale Platforms
利用微型平台了解细胞与细胞连接处的手性
- 批准号:
10587627 - 财政年份:2023
- 资助金额:
$ 39.28万 - 项目类别:
Neural Inflammation and Exercise Pressor Reflex in Heart Failure
心力衰竭中的神经炎症和运动升压反射
- 批准号:
10712202 - 财政年份:2023
- 资助金额:
$ 39.28万 - 项目类别:
Understanding and targeting fibroblast activation in influenza-triggered lung inflammation and post-viral disease
了解和靶向流感引发的肺部炎症和病毒后疾病中的成纤维细胞激活
- 批准号:
10717809 - 财政年份:2023
- 资助金额:
$ 39.28万 - 项目类别:
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 39.28万 - 项目类别:
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
- 批准号:
10677169 - 财政年份:2023
- 资助金额:
$ 39.28万 - 项目类别: